CV SCIENCES, INC. RESCHEDULES FULL YEAR 2019 RESULTS CONFERENCE CALL TO MARCH 16, 2020
10 mars 2020 16h05 HE
|
CV Sciences, Inc.
SAN DIEGO, March 10, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. to Announce Full Year 2019 Results on March 10, 2020
26 févr. 2020 08h00 HE
|
CV Sciences, Inc.
SAN DIEGO, Feb. 26, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. Appoints Dr. Paul Blake to its Board of Directors
22 oct. 2019 08h45 HE
|
CV Sciences, Inc.
SAN DIEGO, Oct. 22, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. to Announce Fourth Quarter and Full Year 2018 Results on March 12, 2019
26 févr. 2019 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, Feb. 26, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced that it will release financial results for its fourth...